IQVIA has grown unchecked into a health data juggernaut. Will the FTC rein it in?
The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel
The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel
First group of healthy volunteers dosed in company’s phase I trial of novel non-hallucinogenic psychoplastogen with no psychotomimetic effects BOSTON, June 20, 2023 /PRNewswire/ — Delix